PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31642175-2	2019	In preclinical and clinical studies, the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor osimertinib has demonstrated activity in the central nervous system (CNS), and studies are ongoing.	Tyrosine	98-106	epidermal growth factor receptor	Homo sapiens	58-90	
31642175-2	2019	In preclinical and clinical studies, the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor osimertinib has demonstrated activity in the central nervous system (CNS), and studies are ongoing.	Tyrosine	98-106	epidermal growth factor receptor	Homo sapiens	92-96